Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
09/05/2018 11:47 am
Bloodwork question about tirzepatide. Baseline, two months in, and the numbers moved in a direction I did not expect.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Sulphur burps and nausea for the first weeks are the usual complaint and they do fade.
What would change your mind about this?